<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>28(11)</volume><submitter>Quintero AM</submitter><pubmed_abstract>Since the COVID-19 pandemic began, different SARS-CoV-2 variants have been identified and associated with higher transmissibility than the ancestral nonvariant strain. During January 1, 2021-January 15, 2022, we assessed differences in clinical and viral parameters in a convenience sample of COVID-19 outpatients and inpatients 0-21 years of age in Columbus, Ohio, USA, according to the infecting variant, identified using a mutation-specific reverse transcription PCR assay. Of the 676 patients in the study, 17.75% were infected with nonvariant strains, 18.49% with the Alpha variant, 41.72% with Delta, and 16.42% with Omicron. Rates of SARS-COV-2/viral co-infections were 15.66%-29.41% and were comparable across infecting variants. Inpatients with acute Delta and Omicron infections had lower S</pubmed_abstract><journal>Emerging infectious diseases</journal><pagination>2270-2280</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9622241</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant.</pubmed_title><pmcid>PMC9622241</pmcid><pubmed_authors>Quintero AM</pubmed_authors><pubmed_authors>Eisner M</pubmed_authors><pubmed_authors>Sayegh R</pubmed_authors><pubmed_authors>Leber AL</pubmed_authors><pubmed_authors>Ramilo O</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Wright T</pubmed_authors><pubmed_authors>Mejias A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant.</name><description>Since the COVID-19 pandemic began, different SARS-CoV-2 variants have been identified and associated with higher transmissibility than the ancestral nonvariant strain. During January 1, 2021-January 15, 2022, we assessed differences in clinical and viral parameters in a convenience sample of COVID-19 outpatients and inpatients 0-21 years of age in Columbus, Ohio, USA, according to the infecting variant, identified using a mutation-specific reverse transcription PCR assay. Of the 676 patients in the study, 17.75% were infected with nonvariant strains, 18.49% with the Alpha variant, 41.72% with Delta, and 16.42% with Omicron. Rates of SARS-COV-2/viral co-infections were 15.66%-29.41% and were comparable across infecting variants. Inpatients with acute Delta and Omicron infections had lower S</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-05T11:57:44.712Z</modification><creation>2025-04-05T11:57:44.712Z</creation></dates><accession>S-EPMC9622241</accession><cross_references><pubmed>36285986</pubmed><doi>10.3201/eid2811.220577</doi></cross_references></HashMap>